Abcam warns on revenues as Covid-19 hits markets
(Sharecast News) - Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.
Read moreWed, 04th Mar 2020 10:26
(Sharecast News) - Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.
Read moreUK BROKER RATINGS SUMMARY: HSBC Downgrades Prudential And Centrica
Read moreAbacam To Raise GBP110 Million Through Share Issue To Fund Growth
Read moreUK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche
Read moreUK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair
Read more(Sharecast News) - Life science research tools company Abcam reported a 10.8% increase in total revenue increased 10.8% on a reported basis and 8.3% on a constant exchange rate basis in its interim results on Monday, to ?138.2m.
Read moreUK WINNERS & LOSERS SUMMARY: Oil Stocks Sink As Brent Price Collapses
Read moreABCAM Profit Down In First Half; Expects Coronavirus To Hurt Revenue
Read moreAbcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreAbcam Buys Applied StemCell Gene Editing Platform, Oncology Portfolio
Read moreDIRECTOR DEALINGS: Abcam's Milner Secures Over GBP15 Million From Sale
Read more